Lifen Hu
Impact in
- Endocrinology top 2%
- Infections and bacterial resistance
- Escherichia coli research studies
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Viral Infections and Vectors 10
- Viral Infections and Outbreaks Research 4
- Antimicrobial Resistance in Staphylococcus 3
-
- Infections and bacterial resistance 6
- Escherichia coli research studies 5
- Co-authors
- Jia-Bin Li (17 shared papers)Ying Ye (11 shared papers)Haifei Yang (12 shared papers)Yanyan Liu (11 shared papers)Jun Cheng (12 shared papers)Jiabin Li (14 shared papers)Guosheng Chen (5 shared papers)Xu Li (2 shared papers)
In The Last Decade
Lifen Hu
47 papers receiving 807 citations
Peers
Comparison fields: 5 of 84
- Endocrinology 295
- Molecular Medicine 265
- Applied Microbiology and Biotechnology 22
- Infectious Diseases 193
- Microbiology 60
Countries citing papers authored by Lifen Hu
This map shows the geographic impact of Lifen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifen Hu more than expected).
Fields of papers citing papers by Lifen Hu
This network shows the impact of papers produced by Lifen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifen Hu. The network helps show where Lifen Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 118 | |
| 2 | 2020 | 65 | |
| 3 | 2016 | 57 | |
| 4 | 2018 | 42 | |
| 5 | 2014 | 35 | |
| 6 | 2017 | 35 | |
| 7 | 2012 | 30 | |
| 8 | 2015 | 30 | |
| 9 | 2016 | 29 | |
| 10 | 2013 | 28 | |
| 11 | 2014 | 25 | |
| 12 | Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China. | 2007 | 25 |
| 13 | 2021 | 22 | |
| 14 | 2015 | 20 | |
| 15 | 2021 | 20 | |
| 16 | 2015 | 20 | |
| 17 | 2013 | 19 | |
| 18 | 2022 | 16 | |
| 19 | 2020 | 16 | |
| 20 | 2012 | 15 |
About Lifen Hu
Lifen Hu is a scholar working on Infectious Diseases, Endocrinology, Molecular Medicine, Molecular Biology and Epidemiology, having authored 48 papers that have together received 823 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Viral Infections and Vectors (10 papers), Infections and bacterial resistance (6 papers), Escherichia coli research studies (5 papers), Viral Infections and Outbreaks Research (4 papers), Vector-Borne Animal Diseases (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial biofilms and quorum sensing (3 papers). The work is most often cited by research in Endocrinology (295 citations), Molecular Medicine (265 citations), Applied Microbiology and Biotechnology (22 citations), Infectious Diseases (193 citations) and Microbiology (60 citations). Lifen Hu has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Jia-Bin Li, Ying Ye, Haifei Yang, Yanyan Liu, Jun Cheng, Jiabin Li, Guosheng Chen, Xu Li, Ying Ye and Wei Shi. Their work appears in journals such as Infection and Drug Resistance, Frontiers in Microbiology, Journal of Microbiology Immunology and Infection, BMC Infectious Diseases and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.